Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation by Taylor, P, Mease, P, Bushmakin, A, Cappelleri, J, Fleischmann, R, Fallon, L, Woolcott, J, Ogdie, A, Azevedo, V, De Vlam, K

Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib by de Vlam, K, Ogdie, A, Bushmakin, A, Cappelleri, J, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J, Mease, P

Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis by Ogdie, A, de Vlam, K, Bushmakin, A, Cappelleri, J, Mease, P, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J